NCIt definition : A selective sodium-glucose co-transporter subtype 2 (SGLT2) inhibitor with antihyperglycemic
activity. Dapagliflozin selectively and potently inhibits SGLT2 compared to SGLT1,
which is the cotransporter of glucose in the gut.;
UNII : 1ULL0QJ8UC;
InChIKey : JVHXJTBJCFBINQ-ADAARDCZSA-N;
CAS number : 461432-26-8; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 461432-26-8
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;